Latest Breaking News On - Department of pharmacy at southern - Page 1 : comparemela.com

A systematic review and meta-analysis suggests the dual pathway-targeting faricimab provides some greater benefit in outcomes like CST at fewer injections and without compromise of safety to anti-VEGF monotherapies.

Guoxian liDrug administrationDepartment of pharmacy at southernSouthern medical university in guangdongSouthern medical universitySouthern medicalSystematic reviewMeta analysisAnti vegf